This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact The Epoch Times Reprints.

The Epoch Times
The Epoch Times
AD
The Epoch Times
INSIDE CHINA

China Reports 1st Case of Dual Infection by Omicron Subvariants

Google LogoMark Us Preferred on Google
China Reports 1st Case of Dual Infection by Omicron Subvariants
Patients on stretchers are seen at Tongren hospital in Shanghai on Jan. 3, 2023. Hector Retamal/AFP via Getty Images
Alex Wu
3/20/2023|Updated: 3/27/2023
0:00

The Chinese communist regime officially reported on March 17 that it has for the first time detected a dual infection of COVID-19 Omicron BA.5.2.48 and BF.7.14 subtypes.

The Chinese Center for Disease Control and Prevention (CDC) stated in a notice on its official website that the case of dual infection was detected in samples collected and submitted for inspection by the Third Affiliated Hospital of Chongqing Medical University on Feb. 14.

According to the notice, the patient reported poor appetite on Dec. 23, 2022, developed fatigue and a cough, and tested positive for COVID-19 on Dec. 29. On Jan. 4, the patient developed chills and fever with a body temperature of 102 degrees F, accompanied by coughing.

He was admitted to Chongqing Yunyang County Hospital of Traditional Chinese Medicine, but his condition didn’t improve. He was discharged on Jan. 5. But on Jan. 6, the patient was admitted to the Department of Infectious Diseases, the Third Affiliated Hospital of Chongqing Medical University. From Jan. 6 to Feb. 12, he was tested eight times for COVID-19, and all the tests were positive.

Researchers collected upper respiratory samples from the patient on Jan. 28 and Feb. 7. Both samples contained specific defining traits for the Omicron subvariants BA.5.2.48 and BF.7.14, indicating that the patient was infected with both simultaneously.

According to the Chinese CDC’s notice, the severe acute respiratory syndrome currently prevalent in Chongqing is mainly caused by the virus strain BA.5.2.48 (responsible for more than 90 percent of cases), followed by BF.7.14 (about 3.8 percent). So far, there have been no other reports of infection with both BA.5.2.48 and BF.7.14 subvariants in China.

A man hugs an elderly relative as he and others offer support as she is cared for in the hallway of a busy emergency room at a hospital in Shanghai on Jan. 14, 2023. (Kevin Frayer/Getty Images)
A man hugs an elderly relative as he and others offer support as she is cared for in the hallway of a busy emergency room at a hospital in Shanghai on Jan. 14, 2023. Kevin Frayer/Getty Images

Netizens Respond

The topic became one of the most searched online in China on March 18, sparking heated discussions.

Mainland Chinese netizens reacted differently to official claims of the first dual infection case.

One wrote: “No big deal, don’t make a fuss. In fact, there are many new variants, and now we don’t make any COVID-19 tests anymore. People don’t know about many new subvariants after they appear. And there is actually no need to know because they still don’t have a very effective way to control it. So just go with the flow and do what you need to do.”

Another wrote, “They just want to sell medicine and vaccines,” and a third post reads: ”COVID-19 has not disappeared. It is still mutating, so everyone should take personal protection.”

Someone else wrote: “Isn’t Influenza A running rampant recently? It’s really frightening that the epidemic comes one after another.”

Influenza A or COVID-19?

Earlier in March, when the Chinese Communist Party’s (CCP’s) Two Sessions political meeting was taking place, a large-scale outbreak of influenza A occurred across mainland China.

In many places, patients who were diagnosed with influenza A saw in CT scans or X-rays that large parts of their lungs had turned white, which is a typical symptom of severe chest infection. So-called “white lung” had been fatal for many COVID-19 patients earlier in the pandemic.

Many netizens questioned whether the wave the government was saying was influenza A could actually be a mutant strain of COVID-19.

Zhang Wenhong, China’s top virologist, said in an interview at the Two Sessions meeting that the next wave of COVID-19 may come in May or June. Since the virus has been downgraded to “Class B,” it will be collectively treated in fever clinics.

It’s unlikely the official data released by the regime are accurate, given the CCP’s history of concealing the truth about the COVID-19 pandemic.

Google LogoMark Us Preferred on Google
Alex Wu
Alex Wu
Author
Alex Wu is a U.S.-based writer for The Epoch Times focusing on Chinese society, Chinese culture, human rights, and international relations.
Author’s Selected Articles
China Reported 79,000 COVID-19 Cases in June, Causing Public Concern
Jul 15, 2026
China Reported 79,000 COVID-19 Cases in June, Causing Public Concern
German Automakers Saw Sharp China Sales Drop in 2nd Quarter
Jul 14, 2026
German Automakers Saw Sharp China Sales Drop in 2nd Quarter
China Omits Job Goal in 5-Year Plan for 1st Time in Decades Amid Persistent High Unemployment
Jul 10, 2026
China Omits Job Goal in 5-Year Plan for 1st Time in Decades Amid Persistent High Unemployment
China and Japan Have a Confrontation Near Disputed Senkaku Islands Amid Rising Tensions in First Island Chain
Jul 10, 2026
China and Japan Have a Confrontation Near Disputed Senkaku Islands Amid Rising Tensions in First Island Chain
Related Topics
covid
Omicron
influenza A
subvariant
AD
Add to My List
Save
The Epoch Times
Copyright © 2000 - 2026 The Epoch Times Association Inc. All Rights Reserved.